Washington University in St. Louis(x)
The Office of Technology Management assists members of the University community in the transfer of technology to private companies for the benefit of society while generating income to support research and education. The OTM manages a wide variety of intellectual properties arising from research programs throughout the University. The areas we address range from patents, copyrights, know-how, and proprietary materials to assisting faculty with consulting agreements and research contracts.
Our current portfolio contains active and pending patents in areas of technology ranging from gene therapies to magnetics. The research projects being conducted by University faculty, students and staff lead to an increasing number of new inventions each year. With federal agency support surpassing $400 million and a history of attracting the finest scientific minds, we are confident that the pace of invention will continue to accelerate. We hope that our work will benefit society and meet the needs of the private sector as well.
posted by Washington University in St. Louis
on 06/05/2007
in Biomedical, Gene Therapy
The invention describes a new reagent for p53 studies. The inventor has created a new p53 ORF containing novel restriction sites for cloning. The new ORF has the same amino acid sequence as the w...
posted by Washington University in St. Louis
on 03/07/2007
in Drug Screening
The current invention describes a prostate specific mTOR knockout mouse generated by crossing TSC1-LoxP mice with transgenic mice expressing cre recombinase under the control of the androgen promot...
posted by Washington University in St. Louis
on 03/07/2007
in Drug Screening
The current invention describes a novel transgenic mouse in the FVB/n strain background that expresses constitutively active mTOR under the prostate-specific probasin promoter. Mice develop consti...
posted by Washington University in St. Louis
on 01/15/2007
in Chemicals, Devices, Nanotechnology, Biomedical
Washington University is actively seeking partners to further develop an innovative new contrast agent for magnetic resonsnace imaging that could revolutionize diagnostic imaging. The agent, which...
posted by Washington University in St. Louis
on 01/05/2007
in Diagnostic, Biomedical
The Spatial Delayed Response (SDR) Task or Oculo-motor delayed response (OMDR) task has been used extensively for assessing spatial working memory.
posted by Washington University in St. Louis
on 01/03/2007
in Animal/Veterinary, Biomedical
A hybridoma cell line that produces monoclonal antibodies (mAbs) against murine ABCA1 transporter protein.
posted by Washington University in St. Louis
on 01/03/2007
in Genomics/Genetics
We are offering a cloning vector containing a pgk-neo cassette flanked by 2 LoxP sites. When used in conjunction with the cre-recombinase, the vector allows for the removal of the pgk-neo cassette.
posted by Washington University in St. Louis
on 01/03/2007
in Diagnostic, Imaging, Chemicals, Biomedical
“Researchers at Washington University have developed a contrast agent with a superior contrast-to-noise ratio; the agent exhibits no background tissue signal, does not depend on the conventio...
posted by Washington University in St. Louis
on 12/15/2006
in Therapeutic, Biomedical
This technology provides methods to grow new kidneys using renal porcine primordial tissue.
posted by Washington University in St. Louis
on 12/11/2006
in Bioinformatics, Computer Software, Genomics/Genetics
PolyBayes is a computer program for the automated analysis of single-nucleotide polymorphism (SNP) discovery in redundant DNA sequences. The primary motivation for its development is to provide a g...
